🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523678-17-00
Authorised Phase I

Phase 1b study to assess the safety and tolerability of SR-878 in patients with rheumatoid arthritis

2025-523678-17-00 · tracked via the Priya Life Science EU tracker
Sponsor
SciRhom GmbH
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
24/04/2026
Enrollment target
12
Sites
Romania

Condition studied

rheumatoid arthritis

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523678-17-00 on CTIS ↗ ← All trials in the EU